True North Advisors LLC Grows Stake in U.S. Physical Therapy, Inc. (NYSE:USPH)

True North Advisors LLC grew its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 22.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,826 shares of the company’s stock after purchasing an additional 1,438 shares during the period. True North Advisors LLC owned approximately 0.05% of U.S. Physical Therapy worth $662,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the stock. Handelsbanken Fonder AB boosted its position in shares of U.S. Physical Therapy by 25.0% during the third quarter. Handelsbanken Fonder AB now owns 3,000 shares of the company’s stock valued at $254,000 after buying an additional 600 shares during the period. Truist Financial Corp increased its stake in U.S. Physical Therapy by 9.2% in the second quarter. Truist Financial Corp now owns 10,382 shares of the company’s stock worth $960,000 after purchasing an additional 874 shares during the period. Quarry LP lifted its position in shares of U.S. Physical Therapy by 1,291.9% during the second quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after purchasing an additional 478 shares during the last quarter. The Manufacturers Life Insurance Company lifted its position in shares of U.S. Physical Therapy by 4.5% during the second quarter. The Manufacturers Life Insurance Company now owns 7,248 shares of the company’s stock worth $670,000 after purchasing an additional 309 shares during the last quarter. Finally, Marshall Wace LLP boosted its stake in shares of U.S. Physical Therapy by 1.1% during the second quarter. Marshall Wace LLP now owns 35,392 shares of the company’s stock valued at $3,271,000 after purchasing an additional 378 shares during the period.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on USPH. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. Barrington Research reissued an “outperform” rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a research report on Friday, September 20th. Finally, Bank of America restated a “neutral” rating and set a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday.

U.S. Physical Therapy Trading Down 1.3 %

NYSE USPH opened at $77.48 on Wednesday. The firm has a market cap of $1.17 billion, a PE ratio of 62.99, a price-to-earnings-growth ratio of 3.97 and a beta of 1.39. U.S. Physical Therapy, Inc. has a 52 week low of $76.18 and a 52 week high of $113.63. The company has a quick ratio of 1.88, a current ratio of 1.88 and a debt-to-equity ratio of 0.28. The company has a 50 day moving average price of $85.15 and a 200 day moving average price of $94.85.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing the consensus estimate of $0.82 by ($0.09). The business had revenue of $167.19 million during the quarter, compared to analysts’ expectations of $163.34 million. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The firm’s revenue was up 10.4% on a year-over-year basis. During the same period last year, the company earned $0.76 earnings per share. As a group, sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.51 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Friday, August 23rd were issued a $0.44 dividend. The ex-dividend date of this dividend was Friday, August 23rd. This represents a $1.76 dividend on an annualized basis and a yield of 2.27%. U.S. Physical Therapy’s payout ratio is 143.09%.

Insiders Place Their Bets

In related news, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the transaction, the chief operating officer now owns 7,038 shares in the company, valued at $580,635. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the sale, the chief operating officer now owns 7,038 shares in the company, valued at $580,635. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of the business’s stock in a transaction on Tuesday, September 3rd. The shares were purchased at an average price of $86.09 per share, with a total value of $172,180.00. Following the completion of the purchase, the director now owns 18,904 shares in the company, valued at $1,627,445.36. This represents a 0.00 % increase in their position. The disclosure for this purchase can be found here. Insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.